Member Info for bootnk19222

Spot on, if lowly share holders don’t trust the CEO then I’m sure pharmaceutical companies definitely don’t. Tim needs to go before the next raise to fund a P140 Trials. There’s no way the current CEO would be in a position to ask the market for money . Beware the rampers , this is only going one way

Given that the CEO stated companies were already interested and they were awaiting more detail after patent, it’s not looking good. A number have signed NDAs and in the data room. If they were remotely interested then there would be a deal on the table. The CEO has proved time and time again he can’t be trusted with the truth and this RNS is no different. How must will a phase cost share holders in order to firm up data ?

And there you have it, ‘as long as it’s true’ . The last RNS wasn’t true but apparently this one it, really? The CEO has made multiple false claims, true

The only delay is in Tim’s head, in which there are multiple deals with big pharma, the reality is very different

No deal, ten pharma in data room, a CEO with form for telling lies . What’s not to like 😱 I can see a big fund raise to pay for a phase to prove up P140, or has he lied about the validity of P140 as well? Looking like there’s a good chance he has

😂😂😂😂

Bulls..ting CEO with form for making false claims

Post patent NDA data room hasn’t impressed big pharma.

IMM will have to compete a phase to prove P140 after failed p3

Massive dilution coming as PIs will have to pay the bill. Anyone buying in now is trying to catch a falling knife .

Look at it another way. The NDA and data room have now been open for some time . What’s the chance of the deals being so large and complex that it was necessary to extend the deal timeline? My money is on the fact that the CEO is a bullish…er and has form for over egging. He over egged not just the deal but impact of the NDA’d information. Big pharma aren’t interested and want more data from the asset. Failed P3, a fantasist of a CEO and a data room full of unimpressed big pharma . I would suggest the companies next move would be a very small deal on one of their lesser known assets followed by a large raise to take p140 through some sort of phase. All that should take about 2-3 years

We were all warned about the CEOs past bull…ting by LTH and here we all are. Leopards and spots etc. he’s obviously excited about the prospect of a deal and with his tight timelines we were conned into thinking it was already all but done. We are all now aware that the CEO is a fantasist and if his deals are fantasy what does that say about the actual drug ?? Anyone buying now must be insane. I would suggest the drug failed P3 and has a high chance of doing the same . I would also suggest there is no actual deal in the pipeline and there’s a good chance the fantasist CEO with try and go it alone with massive fund raises .

Yep looks like saints another GDR Walt

Saint, what’s with the cryptic messages ?

What DN did, along with very disgruntled share holder, was undermined the scum of a BOD, with dubious intentions. If he hadn’t of intervened the share price would still be at .2p or less with little hope. Let’s not forget the incompetence of the BOD and their very dubious antics

Not sure about 10 to 20 p a share. That’s some going with a billion shares in issue . Unless I’m doing the maths wrong? Scotland /england gradual role out with UAE thrown in. FDA sentiment in the pipeline I still don’t get 10/20p ?

Keep the news /predictions coming Amers, well done 👍

In the old days maybe but not now. Don’t think the codes count these days.

Amers, I understand that, from your past predictions, you have some sort of connection with what’s going on behind the scenes. For the rest of us unfortunate we have no such knowledge just an unscrupulous BOD, at best, and an unknown quantity, DN, who’s gone silent. This all seems like too good to be true and all a bit orchestrated. I’m starting to smell a rat/scam

Amers, I think most holding investors now realise this share is a long shot at best, just way too many variables. Combine this with an unscrupulous self sabotaging BOD and you have a share for the bottom drawer

I can disagree with this. This played out over this board with people allegedly in the know dropping hints and the DN himself making an appearance. The lack of news and lack of posts seems all a bit strange. My gut tells me we’ve been played and this is a scam

O god not carrot again? ‘ I like the stock’ say no more🙄 sound like the utter bull…t he’d come out with

I think people are starting to realise that there won’t be any massive UK role out. The company would have been wiser to put most of its efforts into the US. The best we can hope for is an FDA fast track and an early TO . Probably in 18 months time. WHO knows how many shares in issue we’ll have by then, if not private